Lp-PLA2 (Lipoprotein-Associated Phospholipase A2) Deficiency Lowers Cholesterol Levels and Protects Against Atherosclerosis in Rabbits

被引:6
|
作者
Chen, Jiahuan [1 ]
Zhang, Huanyu [1 ]
Li, Linquan [1 ]
Zhang, Xinwei [1 ]
Zhao, Dazhong [1 ]
Wang, Lingyu [1 ]
Wang, Jiaqi [1 ]
Yang, Ping [1 ,2 ]
Sun, Huan [2 ]
Liu, Kun [2 ]
Chen, Weiwei [2 ]
Li, Lin
Lin, Feng [1 ]
Li, Zhanjun [1 ]
Chen, Y. Eugene [4 ]
Zhang, Jifeng [4 ]
Pang, Daxin [1 ,5 ]
Ouyang, Hongsheng [1 ,5 ]
He, Yuquan [2 ,8 ]
Fan, Jianglin [3 ,7 ]
Tang, Xiaochun [1 ,5 ,6 ]
机构
[1] Jilin Univ, Coll Anim Sci, Changchun, Jilin, Peoples R China
[2] Jilin Univ, Dept Cardiol, China Japan Union Hosp, Changchun, Peoples R China
[3] Univ Yamanashi, Fac Med, Grad Sch Med Sci, Dept Mol Pathol, Kofu, Yamanashi, Japan
[4] Univ Michigan, Ctr Adv Models Translat Sci & Therapeut, Dept Internal Med, Med Ctr, Ann Arbor, MI USA
[5] Jilin Univ, Chongqing Res Inst, Chongqing, Peoples R China
[6] Jilin Univ, Coll Anim Sci, 5333 Xian Rd, Changchun, Peoples R China
[7] Univ Yamanashi, Fac Med, Grad Sch Med Sci, Dept Mol Pathol, Kofu, Yamanashi, Japan
[8] Jilin Univ, Dept Cardiol, China Japan Union Hosp, Changchun, Peoples R China
基金
国家重点研发计划;
关键词
atherosclerosis; cardiovascular diseases; inflammation; lipoproteins; rabbits; ACTIVATING-FACTOR-ACETYLHYDROLASE; CORONARY-ARTERY-DISEASE; PAF-AH ACTIVITY; IMPROVES HYPERLIPIDEMIA; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; DARAPLADIB; RISK; INFLAMMATION; EVENTS;
D O I
10.1161/ATVBAHA.122.317898
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:Elevated plasma Lp-PLA(2) (lipoprotein-associated phospholipase A(2)) activity is closely associated with an increased risk of cardiovascular events. However, whether and how Lp-PLA(2) is directly involved in the pathogenesis of atherosclerosis is still unclear. To examine the hypothesis that Lp-PLA(2) could be a potential preventative target of atherosclerosis, we generated Lp-PLA(2) knockout rabbits and investigated the pathophysiological functions of Lp-PLA(2). Methods:Lp-PLA(2) knockout rabbits were generated using CRISPR/Cas9 system to assess the role of Lp-PLA(2) in plasma lipids regulation and identify its underlying molecular mechanisms. Homozygous knockout rabbits along with wild-type rabbits were fed a cholesterol-rich diet for up to 14 weeks and their atherosclerotic lesions were compared. Moreover, the effects of Lp-PLA(2) deficiency on the key cellular behaviors in atherosclerosis were assessed in vitro. Results:When rabbits were fed a standard diet, Lp-PLA(2) deficiency led to a significant reduction in plasma lipids. The decreased protein levels of SREBP2 (sterol regulatory element-binding protein 2) and HMGCR (3-hydroxy-3-methylglutaryl coenzyme A reductase) in livers of homozygous knockout rabbits indicated that the cholesterol biosynthetic pathway was impaired with Lp-PLA(2) deficiency. In vitro experiments further demonstrated that intracellular Lp-PLA(2) efficiently enhanced SREBP2-related cholesterol biosynthesis signaling independently of INSIGs (insulin-induced genes). When fed a cholesterol-rich diet, homozygous knockout rabbits exhibited consistently lower level of hypercholesterolemia, and their aortic atherosclerosis lesions were significantly reduced by 60.2% compared with those of wild-type rabbits. The lesions of homozygous knockout rabbits were characterized by reduced macrophages and the expression of inflammatory cytokines. Macrophages of homozygous knockout rabbits were insensitive to M1 polarization and showed reduced DiI-labeled lipoprotein uptake capacity compared with wild-type macrophages. Lp-PLA(2) deficiency also inhibited the adhesion between monocytes and endothelial cells. Conclusions:These results demonstrate that Lp-PLA(2) plays a causal role in regulating blood lipid homeostasis and Lp-PLA(2) deficiency protects against dietary cholesterol-induced atherosclerosis in rabbits. Lp-PLA(2) could be a potential target for the prevention of atherosclerosis.
引用
收藏
页码:E11 / E28
页数:18
相关论文
共 50 条
  • [31] Lipoprotein-associated phospholipase A2 (Lp-PLA2) and markers of oxidative stress in patients with acute heart failure
    Charniot, J. -C.
    Cosson, C.
    Albertini, J. P.
    Bittar, R.
    Giral, P.
    Cherfils, C.
    Guillerm, E.
    Bonnefont-Rousselot, D.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0F) : F19 - F20
  • [32] Lipoprotein-associated phospholipase A2 (LP-PLA2) may ascertain plaque instability and predict ischemic stroke
    Danihel, L.
    Madarasz, S.
    Blazicek, P.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 129 - 129
  • [33] 4.7 Heritability of Plasma Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): a New Marker of Cardiovascular Risk
    L. Lenzini
    B. Caroccia
    K. Antezza
    R. Wolfert
    R. Szczech
    M. Cesari
    K. Narkiewicz
    C. Williams
    G. Rossi
    High Blood Pressure & Cardiovascular Prevention, 2008, 15 (3) : 209 - 209
  • [34] Biological variability and specificity of lipoprotein-associated phospholipase A2 (Lp-PLA2), a novel marker of cardiovascular risk
    Wolfert, RL
    Kim, NW
    Selby, RG
    Sarno, MJ
    Warnick, RG
    Sudhir, K
    CIRCULATION, 2004, 110 (17) : 309 - 309
  • [35] Lipoprotein-associated phospholipase A2 activity (LP-PLA2) is a marker of small-dense LDL particles
    Gazi, I.
    Lourida, E.
    Filippatos, T.
    Tsimihodimos, V.
    Saougos, V.
    Elisaf, M.
    Tselepis, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 503 - 503
  • [36] Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes
    Canning, Paul
    Kenny, Bridget-Ann
    Prise, Vivien
    Glenn, Josephine
    Sarker, Mosharraf H.
    Hudson, Natalie
    Brandt, Martin
    Lopez, Francisco J.
    Gale, David
    Luthert, Philip J.
    Adamson, Peter
    Turowski, Patric
    Stitt, Alan W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (26) : 7213 - 7218
  • [37] Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL
    Tellis, Constantinos C.
    Tselepis, Alexandros D.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (40) : 6256 - 6269
  • [38] Lipoprotein-associated phospholipase A2 activity (Lp-PLA2) as a predictor of small-dense LDL particles
    Gazi, I.
    Tsimihodimos, V.
    Filippatos, T.
    Lourida, E.
    Elisaf, M.
    Tselepis, A.
    JOURNAL OF HYPERTENSION, 2006, 24 : S395 - S396
  • [39] Resveratrol Treatment Is Associated with Lipid Regulation and Inhibition of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Rabbits Fed a High-Fat Diet
    Xu, Lei
    Wang, Renjie
    Liu, Hongyu
    Wang, Jiaoqi
    Mang, Jing
    Xu, Zhongxin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [40] Smoking induces lipoprotein-associated Phospholipase A2 (Lp-PLA2) in cardiovascular disease free adults: the ATTICA study
    Panagiotakos, D.
    Tselepis, A.
    Pitsavos, C.
    Tellis, C.
    Chrysohoou, C.
    Skoumas, J.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 363 - 363